N/A N=32

Smart-phone Application to Promote Medication Adherence in Adolescents and Young Adults (AYA) With Cancer

Neoplasms

Bottom Line

View on ClinicalTrials.gov: NCT01618344 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Nov 2017

Primary outcome: Primary: Feasibility and Acceptability of Using a Smart-phone Medication Reminder Application to Promote Adherence to Oral Medications by AYA With Cancer. — 21; 13 Participants

Study Design & Population

Study type: Observational
Phase: N/A
Interventions: —
Age: Pediatric, Adult · 15+ yrs
Sex: All
Sponsor: University of Utah
Primary completion: Dec 2016

Outcome Measures

Outcome	Result	p-value
PRIMARY Feasibility and Acceptability of Using a Smart-phone Medication Reminder Application to Promote Adherence to Oral Medications by AYA With Cancer.	21; 13	—

Summary

To explore use of a smart-phone medication reminder application to promote adherence to oral medications by AYA with cancer.

Eligibility Criteria

Inclusion criteria

1)15-29 year olds receiving treatment for any type of cancer, either primary or recurrent/relapsed disease.

Patient has completed at least one month of therapy

3)Patient is expected to remain on therapy for 3 month duration of study

Patient has an iPhone, iPad, or iTouch running iOS 4.0 or later
Patient is willing to use a smart-phone medication reminder application-

Exclusion Criteria

1)Patients who are unable to speak/read/write English as required for use of smart-phone medication reminder application and completion of study measures.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01618344). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.